Evaluation of Healthcare Utilisation and Expenditures in Persons with Type 2 Diabetes Undergoing Bariatric-Metabolic Surgery.
Valerie M MonpellierRose J GeurtenIgnace M C JanssenDirk RuwaardJeroen N StruijsPeter R van DijkHenk J G BiloArianne Mathilda Josephus ElissenPublished in: Obesity surgery (2024)
BMS in people with T2DM stabilises healthcare expenditures and decreases medication use and care use for microvascular complications. In contrast, healthcare use and expenditures in T2DM patients who do not undergo surgery gradually increase over time. Due to the progressive nature of T2DM, it is expected that these differences will become larger in the long-term.
Keyphrases
- healthcare
- minimally invasive
- coronary artery bypass
- health insurance
- glycemic control
- magnetic resonance
- palliative care
- weight loss
- health information
- computed tomography
- risk factors
- affordable care act
- bariatric surgery
- roux en y gastric bypass
- magnetic resonance imaging
- quality improvement
- metabolic syndrome
- adipose tissue
- skeletal muscle
- atrial fibrillation
- insulin resistance
- pain management
- percutaneous coronary intervention
- obese patients